Adial Pharmaceuticals Plans To Change Corporate Name To Azora Therapeutics, Nasdaq Ticker to AZR, Effective Oct. 29
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a biopharmaceutical company developing treatments for serious inflammatory diseases, today announced that it has changed its corporate name to Azora Therapeutics, Inc. The
A company called Adial is changing its name to Azora Therapeutics. The stock ticker will change from ADIL to AZR on October 29th. When a company renames itself, watch if they explain why. A new name sometimes means new focus, but the real business still matters most.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.